What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Heart failure
- Cardiology
Bertram Pitt mainly focuses on Internal medicine, Cardiology, Heart failure, Myocardial infarction and Ejection fraction.
His work deals with themes such as Placebo, Endocrinology and Surgery, which intersect with Internal medicine.
His Cardiology study integrates concerns from other disciplines, such as Relative risk and Randomized controlled trial.
Bertram Pitt has researched Heart failure in several fields, including Hazard ratio, Heart disease, Renal function and Intensive care medicine.
The Myocardial infarction study combines topics in areas such as Artery and Pravastatin.
His Ejection fraction research includes elements of Tolerability, Asymptomatic, Placebo-controlled study, Enalapril and Sudden cardiac death.
His most cited work include:
- The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators. (6838 citations)
- Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. (6679 citations)
- Eplerenone, a Selective Aldosterone Blocker, in Patients with Left Ventricular Dysfunction after Myocardial Infarction (3784 citations)
What are the main themes of his work throughout his whole career to date?
His primary areas of investigation include Internal medicine, Cardiology, Heart failure, Myocardial infarction and Ejection fraction.
His Internal medicine study combines topics from a wide range of disciplines, such as Placebo and Endocrinology.
He interconnects Diabetes mellitus, Randomized controlled trial, Blood pressure and Mineralocorticoid receptor in the investigation of issues within Cardiology.
The concepts of his Heart failure study are interwoven with issues in Aldosterone, Hyperkalemia, Intensive care medicine and Hazard ratio.
His Myocardial infarction research incorporates elements of Artery and Angioplasty.
His study on Ejection fraction is mostly dedicated to connecting different topics, such as Heart disease.
He most often published in these fields:
- Internal medicine (84.62%)
- Cardiology (70.89%)
- Heart failure (52.66%)
What were the highlights of his more recent work (between 2017-2021)?
- Internal medicine (84.62%)
- Heart failure (52.66%)
- Cardiology (70.89%)
In recent papers he was focusing on the following fields of study:
His primary scientific interests are in Internal medicine, Heart failure, Cardiology, Ejection fraction and Heart failure with preserved ejection fraction.
In general Internal medicine, his work in Myocardial infarction, Spironolactone and Proportional hazards model is often linked to In patient linking many areas of study.
His work carried out in the field of Heart failure brings together such families of science as Kidney disease, Renal function, Placebo, Hazard ratio and Hyperkalemia.
His biological study spans a wide range of topics, including Aldosterone, Mineralocorticoid receptor and Blood pressure.
His Ejection fraction research includes themes of Natriuretic peptide, Interquartile range, Incidence and Cohort.
His research in Heart failure with preserved ejection fraction intersects with topics in Cardiac function curve, Quality of life, Candesartan and Sudden death.
Between 2017 and 2021, his most popular works were:
- Iron management in chronic kidney disease: conclusions from a “Kidney Disease: Improving Global Outcomes” (KDIGO) Controversies Conference (190 citations)
- Sotagliflozin in Patients with Diabetes and Recent Worsening Heart Failure (92 citations)
- Factors associated with underuse of mineralocorticoid receptor antagonists in heart failure with reduced ejection fraction: an analysis of 11 215 patients from the Swedish Heart Failure Registry. (64 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Heart failure
- Cardiology
Bertram Pitt focuses on Internal medicine, Heart failure, Cardiology, Ejection fraction and Kidney disease.
His Spironolactone, Myocardial infarction and Randomized controlled trial study in the realm of Internal medicine interacts with subjects such as In patient.
His studies in Heart failure integrate themes in fields like Placebo, Aldosterone, Hyperkalemia and Hazard ratio.
As a member of one scientific family, Bertram Pitt mostly works in the field of Cardiology, focusing on Renin–angiotensin system and, on occasion, Adverse outcomes, Angiotensin II and Pathophysiology.
His Ejection fraction study combines topics in areas such as Proportional hazards model, Interquartile range and Incidence.
His research in Kidney disease intersects with topics in Renal function, Urology, Intensive care medicine, Patiromer and Kidney.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
